Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
TARRYTOWN, N.Y.--(BUSINESS WIRE)--Today, Siemens Healthcare Diagnostics announces its entrance into a collaboration with Janssen Pharmaceutica NV to design, develop and commercialize a companion diagnostic test associated with an early-stage compound being developed by Janssen. This compound targets autoantibodies directed against the human ß1-adrenergic receptor (ß1-AR) that may contribute to the development of heart failure.
Help employers find you! Check out all the jobs and post your resume.
